摘要目的明确肝硬化病人肝内胆管细胞癌(IHCC)钆塞酸增强MRI影像特征,强调IHCC和肝细胞癌(HCC)的区别以及对比MRI和CT上结节强化模式。材料与方法该研究经机构伦理委员会批准,并免除知情同意。回顾性分析72例病人的78个IHCC病灶(男61例,平均56.6岁),另有72例病人中77个HCC病灶(男56例,平均56.6岁)作为对照组,评估其钆塞酸MR和CT增强影像,由2名医生独立完成阅片评估。采用单因素和多因素分析对可以鉴别IHCC和HCC的表现进行评估。根据强化标准以及肝脏影像报告和数 Abstract Objective To clarify the features of gadolinium enhanced enhanced MRI of hepatocellular carcinoma (IHCC) in patients with cirrhosis, and to emphasize the difference between IHCC and hepatocellular carcinoma (HCC) and to compare the enhancement patterns of nodules on MRI and CT. Materials and Methods The study was approved by the Institutional Ethics Committee and exempted from informed consent. A retrospective analysis of 72 patients with 78 IHCC lesions (61 males and 56.6 years of age on average), and another 72 patients with 77 HCC lesions (56 males, mean 56.6 years) as a control group to assess the efficacy of gadoxate acid MR And CT enhanced imaging, by two doctors to complete the reading evaluation. Univariate and multivariate analyzes were used to assess the performance of IHCC and HCC. According to intensive criteria and liver imaging reports and numbers